Portal de Periódicos da CAPES

RELATIONSHIP BETWEEN CARCINOEMBRYONIC ANTIGEN AND BLOOD GROUP ANTIGENS A, B, AND LEWIS*

1975; Wiley; Volume: 259; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1975.tb25436.x

1749-6632

J P Mach, Kanwar Vikas Singh, J. Perrinjaquet, S Carrel, Christine Merenda, Dorothy L. MacDonald, A. M. Holburn,

T-cell and B-cell Immunology

Annals of the New York Academy of SciencesVolume 259, Issue 1 p. 389-403 RELATIONSHIP BETWEEN CARCINOEMBRYONIC ANTIGEN AND BLOOD GROUP ANTIGENS A, B, AND LEWIS* J.-P. Mach, J.-P. Mach Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorK. Singh, K. Singh Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorJ. Perrinjaquet, J. Perrinjaquet Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorS. Carrel, S. Carrel Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorC. Merenda, C. Merenda Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorD. MacDonald, D. MacDonald Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorA. Holburn, A. Holburn Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, Switzerland Visiting worker from the MRC Experimental Haematology Unit, St. Mary's Hospital Medical School, London W.2, England.Search for more papers by this author J.-P. Mach, J.-P. Mach Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorK. Singh, K. Singh Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorJ. Perrinjaquet, J. Perrinjaquet Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorS. Carrel, S. Carrel Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorC. Merenda, C. Merenda Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorD. MacDonald, D. MacDonald Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, SwitzerlandSearch for more papers by this authorA. Holburn, A. Holburn Institut de Biochimie, Université de Lausanne Lausanne, Switzerland Unit of Human Cancer Immunology, Lausanne Branch Ludwig Institute for Cancer Research, in conjunction with Policlinique Médicale Universitaire Lausanne, Switzerland Visiting worker from the MRC Experimental Haematology Unit, St. Mary's Hospital Medical School, London W.2, England.Search for more papers by this author First published: August 1975 https://doi.org/10.1111/j.1749-6632.1975.tb25436.xCitations: 15 * This work was supported in part by the Swiss National Science Foundation and the Medical Research Council of Great Britain. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gold, P. & S. O. Freedman. 1965. Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med. 122: 467–481. 2 Martin, F. & M. S. Martin. 1970. Demonstration of antigens related to colonic carcinoma in the human digestive system. Int. J. Cancer 6: 352–360. 3 Burtin, P., E. Martin, M. C. Sabine & S. von Kleist. 1972. Immunological studies of polyps of the colon. J. Nat. Cancer Inst. 48: 25–32. 4 Pusztaszeri, G. & J.-P. Mach. 1973. Carcinoembryonic antigen (CEA) in non-digestive cancerous and normal tissues. Immunochemistry 10: 197–204. 5 Mach, J.-P. & G. Pusztaszeri. 1972. Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry 9: 1031–1034. 6 Von Kleist, S., G. Chavanel & P. Burtin. 1972. Identification of an antigen from normal human tissue that cross-reacts with the carcinoembryonic antigen. Proc. Nat. Acad. Sci. U.S.A. 69: 2492–2494. 7 Darcy, D. A., C. Tuberville & R. James. 1973. Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein. Br. J. Cancer 28: 147–160. 8 Newman, E. S., S. E. Petras, A. Georgiadis & H. J. Hansen. 1974. Interrelationship of carcinoembryonic antigen and colon carcinoma antigen. III. Cancer Res. 34: 2125–2130. 9 Burtin, P., G. Chavanel & H. Hirsch-Marie. 1973. Characterisation of a second normal antigen that cross-reacts with CEA. J. Immunol. 6: 1926–1928. 10 Lo Gerfo, P., F. P. Herter & S. J. Benett. 1972. Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies. Int. J. Cancer 9: 344–348. 11 Turner, M. D., T. A. Olivares, L. Harwell & M. S. Kleinmann. 1972. Further purification of perchlorate soluble antigens from human colonic carcino- mata. J. Immunol. 108: 1328–1339. 12 Gold, J. M. & P. Gold. 1973. The blood group A-like site on the carcinoembryonic antigen. Cancer Res. 33: 2821–2824. 13 Simmons, D. A. R. & P. Perlmann. 1973. Carcinoembryonic antigen and blood group substances. Cancer Res. 33: 313–322. 14 Banjo, C., P. Gold, C. W. Gehrke, S. O. Freedmann & J. Krupey. 1974. Preparations and isolation of immunologically active glycopeptides from carcinoembryonic antigen (CEA). Int. J. Cancer 13: 151–163. 15 Westwood, J. H., E. M. Bessell, M. A. Bukhari, P. Thomas & J. M. Walker. 1974. Studies on the structure of the carcinoembryonic antigen-I. Some deductions on the basis of chemical degradations. Immunochemistry 11: 811–818. 16 Coligan, J. E. & C. W. Todd. 1975. Structural studies on Carcinoembryonic antigen periodate oxidation. Biochemistry 14: 805–810. 17 Lloyd, K. O., E. A. Kabat & E. Licerio. 1968. Immunochemical studies on blood groups. III. Structures and activities of oligosaccharides produced by alcaline degradation of blood-group Lewis substances. Proposed structure of the carbohydrate chain of human blood-group A, B, H, Lea and Leb substances. Biochemistry 7: 2976–2990. 18 Mach, J.-P. & A. Holburn. 1973. Immunochemistry and biochemistry of CEA. Ann. Immunol. (Inst. Pasteur) 124C: 579–581. 19 Holburn, A. M., J.-P. Mach, D. MacDonald & M. Newlands. 1974. Studies of the association of the A, B and Lewis blood group antigens with carcinoem- bryonic antigen (CEA). Immunology 26: 831–843. 20 Krupey, J., T. Wilson, S. O. Freedman & P. Gold. 1972. The preparation of purified Carcinoembryonic antigen of the human digestive system from large quantities of tumour tissue. Immunochemistry 9: 617–622. 21 Cooper, A. G., M. C. Brown, M. E. Kirch & A. H. Rule. 1974. Relationship of Carcinoembryonic antigen to blood substances A and i: evidence that the antigenic sites are on different molecules. J. Immunol. 113: 1246–1251. 22 Gold, J. M., C. Banjo, S. O. Freedman & P. Gold. 1973. Immunochemical studies of the intramolecular heterogeneity of the Carcinoembryonic antigen (CEA) of the human digestive system. J. Immunol. 11: 1872–1879. 23 Martin, F., C. Klepping & J. Guerrin. 1972. Dosage radioimmunologique de l'antigène carcinoembryonnaire circulant, extraction immuno-perchlorique du serum. Arch. Fr. Mal. Appar. Dig. 61: 725–731. 24 Burtin, P. & G. Chavanel. 1973. A new and fast method of preparation of CEA. Ann. Immunol. (Inst. Pasteur) 124C: 583–587. 25 Awdeh, Z. L., A. R. Williamson & B. A. Askonas. 1968. Isoelectric focussing in polyacrylamide gel and its application to immunoglobulins. Nature 219: 66–67. 26 Carrel, S., L. Theilkaes, F. Skvaril & S. Barandun. 1969. Gel-electrofocussing in combination with immunodiffusion. J. Chromatog. 45: 483–486. 27 Singh, K., W. Wojnarowski, H. Jaquet, G. Pardoe & J.-P. Mach. Immunochemical studies of Carcinoembryonic antigen (CEA). In preparation. 28 Baldwin, R. W., M. R. Price & R. A. Robins. 1973. Significance of serum factors modifying cellular immune responses to growing tumours. Br. J. Cancer 28(Suppl. I): 37–44. 29 Perrinjaquet, J., J. C. Cerottini & J.-P. Mach. Description of a method for the detection of immune complexes between CEA and human immunoglobulins. In preparation. 30 Mach, J.-P., S. Carrel, C. Merenda, B. Sordat & J. C. Cerottini. 1974. In vivo localisation of radiolabelled antibodies to Carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248: 704–706. 31 Mach. J.-P., Ph. Jaeger, M.-M. Bertholet. Ch. Ruegsegger, R. M. Loosli & J. Patgavel. 1974. Detection of recurrence of large-bowel carcinoma by radio-immunoassay of circulating Carcinoembryonic antigen (CEA). Lancet ii: 535–540. 32 Burkhard, M., H. Jaquet, O. de Rham, R. Fritsche, A. Holburn & J.-P. Mach. 1973. Carbohydrate analysis of Carcinoembryonic antigen preparations containing different blood group specificities. Experientia (Basel) 29: 751. 33 Marz, L. & O. P. Bahl. 1973. Blood group activity of human chorionic gonadotropin. Biochem. Biophys. Research Commun. 55: 717–723. Citing Literature Volume259, Issue1Carcinofetal Proteins: Biology and ChemistryAugust 1975Pages 389-403 ReferencesRelatedInformation